895 Discovery of a safer 4–1BB agonist by targeting a membrane-proximal epitope combined with bispecific-mediated cross-bridging

Ítems similars

• 895 Discovery of a safer 4–1BB agonist by targeting a membrane-proximal epitope combined with bispecific-mediated cross-bridging
  per: Bin Li, et al.
  Publicat: (2021-11-01)
• VHH-Based Bispecific Antibodies Targeting Cytokine Production
  per: Maxim A. Nosenko, et al.
  Publicat: (2017-09-01)
• Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
  per: Nika M. Strokappe, et al.
  Publicat: (2019-06-01)
• In vivo neutralization of α-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody.
  per: Gabrielle Richard, et al.
  Publicat: (2013-01-01)
• Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions
  per: Michael Mullin, et al.
  Publicat: (2024-12-01)